Depression and cardiovascular sequelae in postmenopausal women. The Women's Health Initiative (WHI)
Wassertheil-Smoller, Sylvia ; Shumaker, Sally A. ; Ockene, Judith K. ; Talavera, Greg A. ; Greenland, Philip ; Cochrane, Barbara B. ; Robbins, John ; Aragaki, Aaron K. ; Dunbar-Jacob, Jacqueline
Citations
Student Authors
Faculty Advisor
Academic Program
UMass Chan Affiliations
Document Type
Publication Date
Keywords
Antidepressive Agents
Cardiovascular Diseases
Continental Population Groups
Depression
Dose-Response Relationship, Drug
Estrogens
Exercise
Female
Follow-Up Studies
Humans
Life Style
Middle Aged
Motor Activity
Postmenopause
Predictive Value of Tests
Prevalence
Progesterone
Proportional Hazards Models
Prospective Studies
Risk Factors
Statistics as Topic
Survival Analysis
Treatment Outcome
United States
Women's Health
Life Sciences
Medicine and Health Sciences
Women's Studies
Subject Area
Embargo Expiration Date
Link to Full Text
Abstract
BACKGROUND: Subclinical depression, often clinically unrecognized, may pose increased risk of cardiovascular disease. Few studies have prospectively investigated cardiovascular events related to depression in older women. We describe prevalence, cardiovascular correlates, and relationship to subsequent cardiovascular events of depressive symptoms among generally healthy postmenopausal women.
METHODS: The Women's Health Initiative Observational Study followed up 93 676 women for an average of 4.1 years. Depression was measured at baseline with a short form of the Center for Epidemiological Studies Depression Scale. Risks of cardiovascular disease (CVD) events were estimated from Cox proportional hazards models adjusting for multiple demographic, clinical, and risk factor covariates.
RESULTS: Current depressive symptoms above the screening cutoff point were reported by 15.8% of women. Depression was significantly related to CVD risk and comorbidity (odds ratios ranging from 1.12 for hypertension to 1.60 for history of stroke or angina). Among women with no history of CVD, depression was an independent predictor of CVD death (relative risk, 1.50) and all-cause mortality (relative risk, 1.32) after adjustment for age, race, education, income, diabetes, hypertension, smoking, high cholesterol level requiring medication, body mass index, and physical activity. Taking antidepressant medications did not alter the depression-associated risks associated.
CONCLUSIONS: A large proportion of older women report levels of depressive symptoms that are significantly related to increased risk of CVD death and all-cause mortality, even after controlling for established CVD risk factors. Whether early recognition and treatment of subclinical depression will lower CVD risk remains to be determined in clinical trials.
Source
Arch Intern Med. 2004 Feb 9;164(3):289-98. Link to article on publisher's site